Author: Lim, Jaegyun; Jeon, Seunghyun; Shin, Hyun-Young; Kim, Moon Jung; Seong, Yu Min; Lee, Wang Jun; Choe, Kang-Won; Kang, Yu Min; Lee, Baeckseung; Park, Sang-Joon
Title: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR Document date: 2020_2_14
ID: t159ctrv_9
Snippet: The patient also complained of psychiatric symptoms such as depression, insomnia and suicidal thoughts after isolation. The patient experienced stress regarding people's reactions from the media reports about the COVID-19 patients. In addition, despite mild symptoms of COVID-19 in his case, isolation in the negative pressure room during treatment might be one This case shows that the COVID-19 may induce relatively mild symptoms and a patient can .....
Document: The patient also complained of psychiatric symptoms such as depression, insomnia and suicidal thoughts after isolation. The patient experienced stress regarding people's reactions from the media reports about the COVID-19 patients. In addition, despite mild symptoms of COVID-19 in his case, isolation in the negative pressure room during treatment might be one This case shows that the COVID-19 may induce relatively mild symptoms and a patient can recover when early diagnosis of pneumonia was made. 3 -5 When lopinavir/ritonavir was used, we found reduced viral loads and improved clinical symptoms during the treatment. So lopinavir/ritonavir can be recommended to relatively high-risk groups of COVID-19 pneumonia (elderly patients or patients with underlying diseases) from the early stage. But we need more evidence to prove the clinical efficacy of lopinavir/ritonavir based on well controlled clinical trials.
Search related documents:
Co phrase search for related documents- clinical efficacy and control clinical trial: 1, 2, 3, 4
- clinical efficacy and early diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- clinical efficacy and early stage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- clinical efficacy and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical efficacy and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical efficacy and lopinavir ritonavir clinical efficacy: 1, 2, 3, 4, 5, 6
- clinical efficacy and mild symptom: 1, 2
- clinical symptom and early diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- clinical symptom and early stage: 1, 2, 3, 4, 5
- clinical symptom and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- clinical symptom and lopinavir ritonavir: 1
- clinical symptom and mild symptom: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- clinical trial and control clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and early diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- clinical trial and elderly patient: 1
- clinical trial and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and lopinavir ritonavir clinical efficacy: 1, 2
- clinical trial and medium report: 1
Co phrase search for related documents, hyperlinks ordered by date